UNIVERSITY OF UTAH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1850-02-28

Employees: 10K

Market Cap: -

Website: http://www.utah.edu

Clinical Trials

Shared Decision for Drug Interactions in Oral Anticoagulation

Not Applicable

Active, not recruiting

Conditions: Anticoagulants
Drug Interactions

Interventions: Other: Shared Decision Making Tool

First Posted Date: 2024-05-07

Last Posted Date: 2024-05-07

Lead Sponsor: University of Utah

Target Recruit Count: 3691

Registration Number: NCT06401863

Locations: 🇺🇸
Vanderbilt University, Nashville, Tennessee, United States
🇺🇸
University of Utah, Salt Lake City, Utah, United States
🇺🇸
University of Colorado. School of Medicine, Denver, Colorado, United States

Pirtobrutinib in Combination With Rituximab in Newly Diagnosed Marginal Zone Lymphoma (R+Pirto in Newly Diagnosed MZL)

Phase 2

Not yet recruiting

Conditions: Marginal Zone Lymphoma

Interventions: Drug: Pirtobrutinib

First Posted Date: 2024-04-30

Last Posted Date: 2024-10-18

Lead Sponsor: University of Utah

Target Recruit Count: 23

Registration Number: NCT06390956

Locations: 🇺🇸
Huntsman Cancer Institute at University of Utah, Salt Lake City, Utah, United States

Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits

Not Applicable

Not yet recruiting

Conditions: Chronic Pain
Opioid-Related Disorders
Prescription Opioid Misuse
Chemically-Induced Disorders
Neurologic Manifestations
Substance-Related Disorders
Pain
Narcotic-Related Disorders
Mental Disorders

Interventions: Behavioral: Mindfulness Oriented Recovery Enhancement
Behavioral: Patient-Centered Chronic Pain Management Visits

First Posted Date: 2024-04-29

Last Posted Date: 2024-07-16

Lead Sponsor: University of Utah

Target Recruit Count: 300

Registration Number: NCT06387290

Locations: 🇺🇸
Rutgers University Primary Care Clinics, New Brunswick, New Jersey, United States
🇺🇸
University of Utah Primary Care Clinics, Salt Lake City, Utah, United States

Early Weight Bearing in Unicondylar Tibial Plateau Fractures

Conditions: Early Mobilization

Interventions: Other: 6 weeks post-operatively early weight bearing
Other: 10 weeks post-operatively weight bearing (standard of care)

First Posted Date: 2024-04-29

Last Posted Date: 2024-11-22

Lead Sponsor: University of Utah

Target Recruit Count: 60

Registration Number: NCT06389240

Locations: 🇺🇸
University of Utah Orthopedics, Salt Lake City, Utah, United States

Clinical Characteristics and Temporal Properties of Individual Tics in Persistent Tic Disorder

Not Applicable

Recruiting

Conditions: Tic Disorders
Vocal Tic
Tourette Syndrome in Children
Tics/Tremor
Tics
Tourette Syndrome in Adolescence
Motor Tic
Tourette Syndrome

Interventions: Behavioral: Habit Reversal Training (HRT)

First Posted Date: 2024-04-26

Last Posted Date: 2024-04-26

Lead Sponsor: University of Utah

Target Recruit Count: 12

Registration Number: NCT06385535

Locations: 🇺🇸
University of Utah, Salt Lake City, Utah, United States

Real-Time Biofeedback on Partial Weightbearing Training

Active, not recruiting

Conditions: Physical Therapy

Interventions: Other: Verbal Advice
Other: Bathroom Scale
Device: Loadsol Biofeedback

First Posted Date: 2024-04-16

Last Posted Date: 2024-11-22

Lead Sponsor: University of Utah

Target Recruit Count: 105

Registration Number: NCT06368778

Locations: 🇺🇸
University of Utah Orthopaedic Center, Salt Lake City, Utah, United States

The Acute T-Rex (Timing of Resistance Exercise) Study

Not Applicable

Recruiting

Conditions: Diabetes Mellitus, Type 2
Sleep Disturbance
Glucose Intolerance
Insulin Sensitivity
Insulin Resistance
Overweight or Obesity

Interventions: Behavioral: Resistance Exercise Timing

First Posted Date: 2024-04-15

Last Posted Date: 2024-04-15

Lead Sponsor: University of Utah

Target Recruit Count: 20

Registration Number: NCT06366399

Locations: 🇺🇸
University of Utah HPER E Buildling, Salt Lake City, Utah, United States

Neoadjuvant Ipilimumab/Nivolumab for Patients With Recurrent, High Risk, Resectable Melanoma

Phase 2

Recruiting

Conditions: Melanoma

Interventions: Drug: Ipilimumab
Drug: Nivolumab

First Posted Date: 2024-04-15

Last Posted Date: 2024-12-11

Lead Sponsor: University of Utah

Target Recruit Count: 25

Registration Number: NCT06365619

Locations: 🇺🇸
Huntsman Cancer Institute, Salt Lake City, Utah, United States

Topical Tretinoin Prophylaxis for Anti-EGFR Induced Skin Toxicity in Metastatic Colorectal Cancer

Phase 2

Recruiting

Conditions: Metastatic Rectum Cancer
Metastatic Colon Cancer

Interventions: Drug: Topical Tretinoin
Other: Placebo

First Posted Date: 2024-04-10

Last Posted Date: 2024-06-25

Lead Sponsor: University of Utah

Target Recruit Count: 25

Registration Number: NCT06358677

Locations: 🇺🇸
Huntsman Cancer Institute at University of Utah, Salt Lake City, Utah, United States

Physiology of Unloading VA ECMO Trial

Phase 2

Recruiting

Conditions: Cardiogenic Shock

Interventions: Device: IABP

First Posted Date: 2024-03-29

Last Posted Date: 2024-11-12

Lead Sponsor: University of Utah

Target Recruit Count: 104

Registration Number: NCT06336655

Locations: 🇺🇸
University of Utah, Salt Lake City, Utah, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy